• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Adoptive immunotherapy: A new era for the treatment of cancer

PK Darcy, PJ Neeson

Immunotherapy | FUTURE MEDICINE LTD | Published : 2015

DOI: 10.2217/imt.15.37

University of Melbourne Researchers

Phillip Darcy's Profile Picture
Phillip Darcy Author

Paul Neeson's Profile Picture
Paul Neeson Author

Related Projects (3)

Project icon

UTILIZATION OF GENE-ENGINEERED T CELLS FOR ENHANCING CANCER IMMUNOTHERAPY

Killer T lymphocytes can penetrate tumours and their transfer into cancer patients has demonstrated some encouraging results, but this form ..

Project icon

Investigating the limits of adoptive immunotherapy

White blood cells from cancer patients can be modified in the laboratory to react against tumours. Although these cells can induce cancer re..

Project icon

IMMUNE REGULATION EFFECTOR FUNCTION AND THERAPY

We seek to understand how white blood cells detect and destroy disease, and how molecules of the immune system punch holes in diseased cells..

Grants

Awarded by NHMRC Senior Research Fellowship


Awarded by National Health and Medical Research Council


Citation metrics

3Scopus
1Web of Science
5Dimensions

Keywords

Lymphocytes
Immunosuppression
Cancer
Life Sciences & Biomedicine
3211 Oncology and Carcinogenesis
Regression
Chimeric Antigen Receptor
Cytokines
3204 Immunology
Toxicity
T-Cells
Science & Technology
Adoptive Immunotherapy
T Cells
Persistence
32 Biomedical and Clinical Sciences
Immunology

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224